Treatment of poor-prognosis sex cord-stromal tumors of the ovary with the combination of bleomycin, etoposide, and cisplatin

Obstetrics and Gynecology

Volumn 87, Issue 4, 1996, Pages 527-531

  Gershenson, David M ^a   Morris, Mitchell ^b   Burke, Thomas W ^b   Levenback, Charles ^b   Matthews, Carolyn M ^b   Wharton, J Taylor ^b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CISPLATIN; ETOPOSIDE;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CHILD; CLINICAL ARTICLE; DRUG RESPONSE; DRUG SCREENING; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LUNG TOXICITY; NEUTROPENIA; OVARY TUMOR; PRIORITY JOURNAL; PROGNOSIS; SEX CORD TUMOR; THROMBOCYTOPENIA;

EID: 0029879230     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1016/0029-7844(95)00491-2     Document Type: Article

References (27)

1. Young RH, Scully RE. Ovarian Sertoli-Leydig cell tumors. A clinico-pathological analysis of 207 cases. Am J Surg Pathol 1985; 9:543-69.
2. Roth LM, Anderson MC, Govan ADT, Langley FA, Gowing NF, Woodcock AS. Sertoli-Leydig cell tumors: A clinicopathologic study of 34 cases. Cancer 1981;48:187-97.
3. Zaloudek C, Norris HJ. Sertoli-Leydig tumors of the ovary: A clinicopathologic study of 64 intermediate and poorly differentiated neoplasms. Am J Surg Pathol 1984;8:405-17.
4. Stenwig JT, Hazekamp JT, Beecham JB. Granulosa cell tumors of the ovary: A clinicopathological study of 118 cases with long-term follow-up. Gynecol Oncol 1979;7:136-52.
5. Evans AT, Gaffey TA, Malkasian GD Jr, Annegers JF. Clinicopathologic review of 118 granulosa and 82 theca cell tumors. Obstet Gynecol 1980;55:231-8.
6. Pankratz E, Boyes DA, White GW, Galliford BW, Fairey RN, Benedet JL. Granulosa cell tumors: A clinical review of 61 cases. Obstet Gynecol 1978;52:718-23.
7. Bjorkholm E, Silfversward C. Prognostic factors in granulosa-cell tumors. Gynecol Oncol 1981;11:261-74.
8. Ohel G, Kaneti H, Schenker JG. Granulosa cell tumors in Israel: A study of 172 cases. Gynecol Oncol 1983;15:278-86.
9. Jacobs AJ, Deppe G, Cohen CJ. Combination chemotherapy of ovarian granulosa cell tumor with cis-platinum and doxorubicin. Gynecol Oncol 1982;14:294-7.
10. Pride GL, Pollock WJ, Norgard MJ. Metastatic Sertoli-Leydig cell tumor of the ovary during pregnancy treated by BV-CAP chemotherapy. Am J Obstet Gynecol 1982;143:231-3.
11. Camlibel FT, Caputo TA. Chemotherapy of granulosa cell tumors. Am J Obstet Gynecol 1983:145:763-5.
12. Kaye SB, Davies E. Cyclophosphamide, adriamycin, and cisplatinum for the treatment of advanced granulosa cell tumors, using serum estradiol as a tumor marker. Gynecol Oncol 1986;24:261-4.
13. Gershenson DM, Copeland LJ, Kavanagh JJ, Stringer CA, Saul PB, Wharton JT. Treatment of metastatic stromal tumors of the ovary with cisplatin, doxorubicin, and cyclophosphamide. Obstet Gynecol 1987;70:765-9.
14. Colombo N, Sessa C, Landoni F, Sartori E, Pecorelli S, Mangioni C. Cisplatin, vinblastine, and bleomycin combination chemotherapy in metastatic granulosa cell tumor of the ovary. Obstet Gynecol 1986;67:265-8.
15. Zambetti M, Escobedo A, Pilotti S, De Palo G. Cisplatinum/ vinblastine/bleomycin combination chemotherapy in advanced or recurrent granulosa cell tumors of the ovary. Gynecol Oncol 1990;36: 317-20.
16. Serov SF, Scully RE, Sobin LJ. Histological typing of ovarian tumors. In: World Health Organization: International Histological Classification of Tumors. Geneva: The World Health Organization, 1973.
17. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
18. Dinnerstein AJ, O'Leary JA. Granulosa-theca cell tumors: A clinical review of 102 patients. Obstet Gynecol 1968;31:654-8.
19. Schwartz PE, Smith JP. Treatment of ovarian stromal tumors. Am J Obstet Gynecol 1976;125:402-11.
20. Fox H, Agrawal K, Langley FA. A clinicopathologic study of 92 cases of granulosa cell tumor of the ovary with special reference to the factors influencing prognosis. Cancer 1975;35:231-41.
21. Norris HJ, Taylor HB. Prognosis of granulosa-theca tumors of the ovary. Cancer 1968;21:255-63.
22. Malmstrom H, Hogberg T, Risberg B, Simonsen B. Granulosa cell tumors of the ovary: Prognostic factors and outcome. Gynecol Oncol 1994;52:50-5.
23. Klemi PK, Joensuu H, Salmi T. Prognostic value of flow cytometric DNA content analysis in granulosa cell tumor of the ovary. Cancer 1990;65:1189-93.
24. Chadha S, Cornelisse CJ, Schabert A. Flow cytometric DNA ploidy analysis of ovarian granulosa cell tumors. Gynecol Oncol 1990;36: 240-5.
25. Hitchcock CL, Norris HJ, Khalifa MA, Wargotz ES. Flow cytometric analysis of granulosa tumors. Cancer 1989;64:2127-32.
26. Swanson SA, Norris HJ, Kelsten ML, Wheeler JE. DNA content of juvenile granulosa tumors determined by flow cytometry. Int J Gynecol Pathol 1990;9:101-9.
27. Tresukosol D, Kudelka AP, Edwards CL, Charnsangavej N, Narboni N, Kavanagh JJ. Recurrent ovarian granulosa cell tumor: A case report of a dramatic response to Taxol. Int J Gynecol Cancer 1995;5:156-9.